Crossmark Global Holdings, Inc. Baxter International Inc Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Baxter International Inc stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 23,366 shares of BAX stock, worth $775,984. This represents 0.02% of its overall portfolio holdings.

Number of Shares

23,366

Previous 23,861 2.07%

Holding current value

$775,984

Previous $798,000 11.15%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$32.85 - $40.26 $16,260 - $19,928	-495 Reduced 2.07%	23,366 $887,000
Q2 2024 Jul 29, 2024	SELL	$32.87 - $43.55 $47,464 - $62,886	-1,444 Reduced 5.71%	23,861 $798,000
Q1 2024 May 13, 2024	SELL	$37.88 - $43.77 $21,174 - $24,467	-559 Reduced 2.16%	25,305 $1.08 Million
Q4 2023 Feb 13, 2024	SELL	$31.71 - $38.95 $25,050 - $30,770	-790 Reduced 2.96%	25,864 $1 Million
Q3 2023 Nov 08, 2023	SELL	$37.32 - $49.29 $6,792 - $8,970	-182 Reduced 0.68%	26,654 $995,000
Q2 2023 Jul 31, 2023	SELL	$39.98 - $47.68 $77,761 - $92,737	-1,945 Reduced 6.76%	26,836 $1.26 Million
Q1 2023 May 12, 2023	SELL	$37.58 - $52.57 $82,939 - $116,021	-2,207 Reduced 7.12%	28,781 $1.17 Million
Q4 2022 Jan 19, 2023	BUY	$49.7 - $57.71 $53,924 - $62,615	1,085 Added 3.63%	30,988 $1.58 Million
Q3 2022 Nov 01, 2022	BUY	$53.86 - $66.8 $11,149 - $13,827	207 Added 0.7%	29,903 $1.61 Million
Q2 2022 Jul 29, 2022	BUY	$63.83 - $80.0 $13,404 - $16,800	210 Added 0.71%	29,696 $1.91 Million
Q1 2022 May 11, 2022	BUY	$76.85 - $89.45 $48,338 - $56,264	629 Added 2.18%	29,486 $2.29 Million
Q4 2021 Jan 10, 2022	SELL	$74.57 - $87.19 $27,665 - $32,347	-371 Reduced 1.27%	28,857 $2.48 Million
Q3 2021 Oct 21, 2021	SELL	$73.77 - $83.61 $2.93 Million - $3.32 Million	-39,739 Reduced 57.62%	29,228 $2.35 Million
Q3 2021 Oct 13, 2021	BUY	$73.77 - $83.61 $2.89 Million - $3.27 Million	39,159 Added 131.37%	68,967 $4.16 Million
Q2 2021 Jul 21, 2021	SELL	$80.5 - $88.01 $10,465 - $11,441	-130 Reduced 0.43%	29,808 $2.4 Million
Q1 2021 Apr 15, 2021	SELL	$76.38 - $86.03 $1,298 - $1,462	-17 Reduced 0.06%	29,938 $2.53 Million
Q4 2020 Jan 14, 2021	BUY	$75.39 - $82.36 $3,015 - $3,294	40 Added 0.13%	29,955 $2.4 Million
Q3 2020 Oct 08, 2020	SELL	$78.33 - $90.73 $122,978 - $142,446	-1,570 Reduced 4.99%	29,915 $2.41 Million
Q2 2020 Aug 14, 2020	SELL	$78.66 - $94.14 $64,265 - $76,912	-817 Reduced 2.53%	31,485 $2.71 Million
Q1 2020 Apr 28, 2020	SELL	$71.57 - $93.3 $1.35 Million - $1.76 Million	-18,831 Reduced 36.83%	32,302 $2.62 Million
Q4 2019 Feb 06, 2020	SELL	$76.7 - $88.45 $1.19 Million - $1.37 Million	-15,509 Reduced 23.27%	51,133 $4.28 Million
Q3 2019 Oct 09, 2019	SELL	$81.4 - $89.78 $93,284 - $102,887	-1,146 Reduced 1.69%	66,642 $5.83 Million
Q2 2019 Jul 09, 2019	SELL	$73.44 - $82.41 $324,237 - $363,840	-4,415 Reduced 6.11%	67,788 $5.55 Million
Q1 2019 May 02, 2019	BUY	$64.48 - $81.31 $208,786 - $263,281	3,238 Added 4.7%	72,203 $5.87 Million
Q4 2018 Jan 31, 2019	SELL	$61.45 - $77.8 $806,899 - $1.02 Million	-13,131 Reduced 15.99%	68,965 $4.54 Million
Q3 2018 Nov 08, 2018	SELL	$70.71 - $77.75 $390,389 - $429,257	-5,521 Reduced 6.3%	82,096 $6.33 Million
Q2 2018 Jul 31, 2018	BUY	$63.43 - $75.41 $1.07 Million - $1.27 Million	16,863 Added 23.83%	87,617 $6.47 Million
Q1 2018 Apr 16, 2018	SELL	$62.56 - $72.26 $520,624 - $601,347	-8,322 Reduced 10.52%	70,754 $4.6 Million
Q4 2017 Feb 05, 2018	BUY	$61.45 - $66.05 $1.57 Million - $1.69 Million	25,522 Added 47.66%	79,076 $5.11 Million
Q3 2016 Oct 25, 2017	BUY	N/A	53,554	53,554 $3.36 Million

Others Institutions Holding BAX

# of Institutions

1,006

Shares Held

451M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Baxter International Inc Transaction History